

LONDON (Alliance News) - Hutchison China MediTech Ltd said Wednesday its majority owned research and development company has begun the first in-human ...


LONDON (Alliance News) - Hutchinson China MediTech Ltd said Thursday that its majority owned research and development company has begun a Phase II cli...


LONDON (Alliance News) - Hutchinson China MediTech Ltd said Wednesday that Independent Non-Executive Director Christopher Nash bought 4,036 shares at ...


LONDON (Alliance News) - Hutchison China MediTech Ltd Friday said Shanghai Traditional Chinese Medicine Co. Ltd has decided to grant the two companies...


LONDON (Alliance News) - Hutchison China MediTech Ltd Friday said its research and development company Hutchison MediPharma Ltd and pharmaceuticals fi...


Alent: Numis moves target price from 330p to 340p upgrading to add. AVEVA Group: Westhouse Securities initiates with a target price of 2260p and a bu...